0001568651FALSE00015686512026-06-042026-06-04

Date of report (Date of earliest event reported): June 4, 2026

75 Varick Street, 5th Floor

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

On June 4, 2026, Oscar Health, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). As of the close of business on April 10, 2026 (the “Record Date”), there were 265,530,268 shares of Class A common stock outstanding, each share being entitled to one vote, and 35,591,356 shares of Class B common stock outstanding, each share of Class B common stock being entitled to 20 votes. At the Annual Meeting, the holders of 820,307,497 votes of the Common Stock were represented in person or by proxy, constituting a quorum.

The stockholders of the Company voted as follows at the Annual Meeting:

Proposal 1 – Election of eight director nominees to serve until the 2027 Annual Meeting:

Nominee						Votes FOR												Votes WITHHELD												Broker Non-Votes
Mark T. Bertolini									772,818,926												1,558,102												45,930,469
William J. Gassen III									750,059,354												24,317,674												45,930,469
Joshua Kushner									773,650,856												726,172												45,930,469
Laura Lang									773,617,446												759,582												45,930,469
David Alexander Plouffe									770,608,329												3,768,699												45,930,469
Siddhartha Sankaran									771,818,551												2,558,477												45,930,469
Mario Schlosser									773,697,551												679,477												45,930,469
Vanessa Ames Wittman									772,915,630												1,461,398												45,930,469

Proposal 2 – Advisory vote to approve named executive officer compensation:

Proposal 3 – Ratification of appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026:

Based on the foregoing votes, the eight director nominees were elected, and Items 2 and 3 were approved.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 9, 2026